ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 133 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $343,000 | +36.1% | 18,132 | -15.4% | 0.00% | – |
| Q2 2019 | $252,000 | +20.6% | 21,428 | +39.7% | 0.00% | – |
| Q1 2019 | $209,000 | +23.7% | 15,339 | -7.3% | 0.00% | – |
| Q4 2018 | $169,000 | -37.2% | 16,546 | +2.6% | 0.00% | – |
| Q3 2018 | $269,000 | +5.5% | 16,123 | -0.0% | 0.00% | – |
| Q2 2018 | $255,000 | +27.5% | 16,131 | +2.6% | 0.00% | – |
| Q1 2018 | $200,000 | -52.6% | 15,717 | -57.4% | 0.00% | – |
| Q4 2017 | $422,000 | +76.6% | 36,881 | +89.1% | 0.00% | – |
| Q3 2017 | $239,000 | +408.5% | 19,505 | +370.8% | 0.00% | – |
| Q2 2017 | $47,000 | -59.8% | 4,143 | -26.0% | 0.00% | – |
| Q1 2017 | $117,000 | +2825.0% | 5,602 | +3047.2% | 0.00% | – |
| Q4 2016 | $4,000 | -33.3% | 178 | 0.0% | 0.00% | – |
| Q3 2016 | $6,000 | +50.0% | 178 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | -50.0% | 178 | -45.1% | 0.00% | – |
| Q1 2016 | $8,000 | +14.3% | 324 | +54.3% | 0.00% | – |
| Q4 2015 | $7,000 | 0.0% | 210 | 0.0% | 0.00% | – |
| Q3 2015 | $7,000 | – | 210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $37,365,000 | 8.14% |
| Foresite Capital Management II, LLC | 1,686,220 | $21,415,000 | 7.12% |
| Foresite Capital Management IV, LLC | 830,919 | $10,553,000 | 4.38% |
| SENZAR ASSET MANAGEMENT, LLC | 822,890 | $10,451,000 | 3.30% |
| Redmile Group, LLC | 6,505,766 | $82,623,000 | 3.19% |
| DAFNA Capital Management LLC | 396,013 | $5,029,000 | 2.45% |
| SECTORAL ASSET MANAGEMENT INC | 863,600 | $10,968,000 | 1.20% |
| Palo Alto Investors LP | 1,849,832 | $23,493,000 | 1.00% |
| Bellevue Group AG | 700,464 | $8,896,000 | 0.88% |
| Rock Springs Capital Management LP | 1,529,800 | $19,428,000 | 0.83% |